Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2008
11/27/2008US20080293595 siRNA targeting protein tyrosine phosphatase-1B (PTP1B)
11/27/2008US20080293593 siRNA targeting casitas B cell lymphoma-B (CBL-B)
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080293123 Compositions comprising viruses and methods for concentrating virus preparations
11/27/2008US20080293116 Ovary-specific genes and proteins
11/27/2008US20080293103 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292611 Novel methods of treatment and delivery modes
11/27/2008US20080292603 Treatment and prevention of neurodegenerative diseases using gene therapy
11/27/2008US20080292593 Gene therapy for spinal cord disorders
11/27/2008CA2688536A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2684879A1 Methods of identifying genes involved in memory formation using small interfering rna (sirna)
11/26/2008EP1995315A2 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/26/2008EP1994176A2 Methods and agents for modulating an immune response
11/26/2008EP1994159A1 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans
11/26/2008EP1994155A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
11/26/2008EP1994152A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/26/2008EP1993612A2 Compositions and methods for treating cognitive disorders
11/26/2008EP1993603A1 Hepatitis c virus non structural fusion protein
11/26/2008EP1993584A2 Compositions and methods for the treatment of ophthalmic disease
11/26/2008EP1515752B1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
11/26/2008EP1257642B1 Partners of ptb1 domain of fe65, preparation and uses
11/26/2008EP1124953B1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
11/26/2008EP0969875B1 Naked dna-mediated gene transfer into medullary motor neurons
11/26/2008CN101311270A Eucaryon expression vector capable of inducing cell immunological response and vaccine thereof
11/26/2008CN101310770A Antibodies against cancer
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436471C Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof
11/26/2008CN100435851C Method and its system for leading large molecular matter into target cell
11/26/2008CN100435850C Combination of medication produced from attenuated salmonella bacteria possessing effect of radiation protection and anti tumour
11/26/2008CN100435849C Anti-tumor agent using interleukin-23 gene
11/26/2008CN100435848C Gene treatment to raise feed efficiency and promote growth of farm animal
11/26/2008CN100435784C Method for preparing inorganic salt nanometer particles containing and packing traditional Chinese medicine and its application
11/25/2008US7456333 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls.
11/25/2008US7456154 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/25/2008US7456015 Nervous system disorder; includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system; tightly regulatable gene delivery vector
11/25/2008US7456009 Adenovirus formulations
11/25/2008US7456008 Modified virus comprising one or more non-native polypeptides
11/25/2008US7455986 Heparinase III and methods of specifically cleaving therewith
11/25/2008US7455964 Genes from the 20q13 amplicon and their uses
11/25/2008US7455963 Antibodies to cyclin E2 protein
11/25/2008US7455842 Chimeric West Nile viruses and uses thereof
11/25/2008US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody
11/25/2008CA2375549C Delivery system for biological material
11/25/2008CA2361318C Novel nucleosides and oligonucleotide analogues
11/25/2008CA2345354C Antisense modulation of bcl-x expression
11/25/2008CA2264776C Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
11/20/2008WO2008141308A2 Gene expression and pain
11/20/2008WO2008140961A2 Papillomavirus pseudoviruses for detection and therapy of tumors
11/20/2008WO2008140571A2 Methods and compositions for treating influenza
11/20/2008WO2008140474A1 Recombinant adenovirus vaccines
11/20/2008WO2008140126A1 Single-stranded cyclic rna, and method for production thereof
11/20/2008WO2008140081A1 Liposome and method for producing liposome
11/20/2008WO2008139938A1 Double-stranded nucleic acid molecule targeting for human papilloma virus type-16 gene, and pharmaceutical agent comprising the molecule
11/20/2008WO2008138533A1 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
11/20/2008WO2008101084A3 Methods and compositions for the disruption of biofilms
11/20/2008WO2008100749A3 Transfection in magnetically driven continuous flow
11/20/2008WO2008097854A3 Method and substances for treating hpv infection
11/20/2008WO2008085828A3 Peptide modulators of angiogenesis and use thereof
11/20/2008WO2008034129A3 Treatment of cancer or obesity with conjugated linoleic acids
11/20/2008WO2007136857A3 Hox compositions and methods
11/20/2008WO2007058968A3 Gene expression profiles and methods of use
11/20/2008WO2006133052A3 A cellular therapy for ocular degeneration
11/20/2008WO2006062647A3 Gene expression and genetic changes implicated in alcoholism
11/20/2008WO2004087055A3 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
11/20/2008US20080287387 Method for Producing Sterile Polynucleotide Based Medicaments
11/20/2008US20080287386 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
11/20/2008US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene
11/20/2008US20080287379 Oligonucleotide Complex Compositions and Methods of Use as Gene Alteration Tools
11/20/2008US20080287348 Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies
11/20/2008US20080286836 Retroviral gene transfer element for enhancement of heterologous gene sequences in cells
11/20/2008US20080286821 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2008US20080286817 Novel allergens and treatment
11/20/2008US20080286813 Antibody specific for mutant presenilin 1 and method of use thereof
11/20/2008US20080286789 Genomic polymorphism for predicting therapeutic response
11/20/2008US20080286781 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
11/20/2008US20080286353 Cationic liposomes containing immune response generating moieties
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286285 Methods for Treating Vascular Disease
11/20/2008US20080286284 Compositions of PSMA antibodies
11/20/2008US20080286283 Treatment of cancer with antibodies to costimulating polypeptide of T cells
11/20/2008US20080286264 Modulation of Muc1 Activity
11/20/2008US20080286261 Methods of modulating hair growth
11/20/2008US20080286250 Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Gdnf
11/20/2008US20080286247 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
11/20/2008US20080286239 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/20/2008US20080286205 Method for Treating Prostate Diseases Based on Local Delivery of Active Substances
11/20/2008CA2723672A1 Gene expression and pain
11/20/2008CA2687301A1 Synthetic herpes simplex viruses type-1 for treatment of cancers
11/20/2008CA2686990A1 Papillomavirus pseudoviruses for detection and therapy of tumors
11/20/2008CA2685994A1 Single-chain circular rna and method of producing the same
11/20/2008CA2676149A1 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
11/19/2008EP1992696A1 Circovirus sequences associated with porcine wasting disease (PWD)
11/19/2008EP1992695A2 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
11/19/2008EP1992640A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
11/19/2008EP1992634A1 Oligonucleotide n3'- p5' thiophosphoramidates: their synthesis and use
11/19/2008EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth
11/19/2008EP1991678A2 Compositions and methods for oligonucleotide formulations
11/19/2008EP1991277A2 Delivery of biologically active materials using core-shell tecto (dendritic polymers)
1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 870